US5385544A
Expired / Lapsed
US
⏱️ 0.0 years remaining
BPH ablation method and apparatus
Assignee: Medtronic Vidamed Inc
•
Filing: 1993-05-14
•
Granted: 1995-01-31
•
Expires: 2013-05-14
Abstract
Abstract A method and an apparatus is disclosed for delivering controlled heat to perform ablation to treat the benign prosthetic hypertrophy or hyperplasia (BPH). According to the method and the apparatus, the energy is transferred directly into the tissue mass which is to be treated in such a manner as to provide tissue ablation without damage to surrounding tissues. Automatic shut-off occurs when any one of a number of surrounding areas to include the urethra or surrounding mass or the adjacent organs exceed predetermined safe temperature limits. The constant application of the radio frequency energy over a maintained determined time provides a safe procedure which avoids electrosurgical and other invasive operations while providing fast relief to BPH with a short recovery time. The procedure may be accomplished in a doctor's office without the need for hospitalization or surgery.
Inventors
- 👤 Stuart D. Edwards
- 👤 Hugh R. Sharkey
- 👤 Ingemar H. Lundquist
- 👤 Ronald G. Lax
- 👤 Bruno Strul
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 23:52
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/02; A61N5/04; A61N5/045; A61B; A61B18/00; A61B18/04; A61B18/12; A61B18/1206; A61B18/14; A61B18/1477; A61B18/1485; A61B18/18; A61B18/1815; A61M; A61M3/00; A61M3/02; A61M3/0279; A61N1/00; A61N1/02; A61N1/04; A61N1/06; A61N1/08; A61N1/40; A61N1/403; A61B10/00; A61B10/02; A61B10/0233; A61B10/0241; A61B18/08; A61B18/082; A61B18/148; A61B18/20; A61B18/22; A61B18/24; A61B17/00; A61B2017/00017; A61B2017/00022; A61B2017/00084; A61B2017/00092; A61B2017/00101; A61B2017/00106; A61B2017/00115; A61B2017/00119; A61B2017/00123; A61B2017/00137; A61B2017/00154; A61B2017/00181; A61B2017/00194; A61B17/00234; A61B2017/00238; A61B2017/00274; A61B2017/00292; A61B2017/003; A61B2017/00831; A61B2017/00867; A61B17/22; A61B2017/22072; A61B2017/22074; A61B2017/22077; A61B2017/22082; A61B17/24; A61B2017/248; A61B17/28; A61B17/29; A61B2017/2926; A61B2017/2932; A61B2017/2939; A61B17/34; A61B2017/348; A61B2017/3482; A61B2017/3484; A61B2017/3488; A61B2018/00005; A61B2018/00011; A61B2018/00053; A61B2018/00059; A61B2018/00071; A61B2018/00083; A61B2018/00089; A61B2018/00095; A61B2018/00101; A61B2018/00184; A61B2018/00196; A61B2018/00214; A61B2018/0022; A61B2018/00315; A61B2018/00547; A61B2018/00571; A61B2018/00577; A61B2018/00636; A61B2018/0066; A61B2018/00666; A61B2018/00678; A61B2018/00696; A61B2018/00702; A61B2018/00726; A61B2018/00732; A61B2018/00744; A61B2018/0075; A61B2018/00761; A61B2018/00773; A61B2018/00779; A61B2018/00791; A61B2018/00797; A61B2018/00821; A61B2018/00869; A61B2018/00875; A61B2018/00886; A61B2018/0091; A61B2018/00916; A61B2018/0094; A61B2018/00946; A61B2018/00982; A61B2018/1246; A61B2018/1253; A61B2018/126; A61B2018/1273; A61B2018/128; A61B2018/1405; A61B2018/1425; A61B2018/2238; A61B90/00; A61B90/08; A61B2090/0814; A61B90/36; A61B90/361; A61B2090/3614; A61B90/37; A61B2090/378; A61B2090/3782; A61B2090/3786; A61B90/39; A61B2090/3925; A61F; A61F7/00; A61F2007/0054; A61M25/00; A61M25/0067; A61M25/0082; A61M25/0084; A61M2025/0085; A61M2025/0086; A61M2025/0087; A61M2025/0096; A61M25/01; A61M2025/018; A61M25/0068
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
231 words
A medical probe device for medical treatment of the prostate, comprising: a catheter having a stylet guide housing at one end; a stylet having a flexible radio-frequency electrode with a sharpened tip and an insulating sleeve that retains the electrode and is movable relative to the electrode; stylet guide means disposed in the stylet guide housing for retaining and directing the stylet outward through a stylet port in a side of the stylet guide housing; means for introducing the catheter through the urethra to a zone adjacent to the prostate; means for advancing the electrode from the catheter through the wall of the urethra into the prostate tissue to be treated such that the sharpened tip of the electrode punctures and penetrates the urethra wall with the sleeve extending through the urethra wall; means for retracting the insulating sleeve within the prostate tissue to expose a predetermined length of electrode in the prostate tissue; power supply means connected to the electrode for passing electric current through the electrode until the temperature of the prostate tissue adjacent the predetermined length of electrode is raised to a temperature causing destruction of cells of the prostate tissue; and first temperature monitoring means connected to the power supply means for measuring the temperature of tissue proximal to the prostate and providing a cut-off of the electric current when the monitored temperature exceeds a predetermined value.
Claim 2
Dependent Claim
231 words
A medical probe device for medical treatment of the prostate, comprising: a catheter having a stylet guide housing at one end; a stylet having a flexible radio-frequency electrode with a sharpened tip and an insulating sleeve that retains the electrode and is movable relative to the electrode; stylet guide means disposed in the stylet guide housing for retaining and directing the stylet outward through a stylet port in a side of the stylet guide housing; means for introducing the catheter through the urethra to a zone adjacent to the prostate; means for advancing the electrode from the catheter through the wall of the urethra into the prostate tissue to be treated such that the sharpened tip of the electrode punctures and penetrates the urethra wall with the sleeve extending through the urethra wall; means for retracting the insulating sleeve within the prostate tissue to expose a predetermined length of electrode in the prostate tissue; power supply means connected to the electrode for passing electric current through the electrode until the temperature of the prostate tissue adjacent the predetermined length of electrode is raised to a temperature causing destruction of cells of the prostate tissue; and first temperature monitoring means connected to the power supply means for measuring the temperature of tissue proximal to the prostate and providing a cut-off of the electric current when the monitored temperature exceeds a predetermined value.
Claim 3
Dependent Claim
24 words
The medical probe device as set forth in claim 1, wherein the stylet guide housing includes at least two stylet ports and stylets therein.
Claim 4
Dependent Claim
26 words
The medical probe device as set forth in claim 1, wherein the power supply is calibrated using an impedance level normally associated with a human male.
Claim 5
Dependent Claim
53 words
The medical probe device as set forth in claim 1, and further including second temperature monitoring means connected to the power supply means for measuring the temperature of a body organ in the vicinity of the prostate and providing a cut-off of the electric current when the monitored temperature exceeds a predetermined value.
Claim 6
Dependent Claim
28 words
The medical probe device as set forth in claim 4, wherein the first and second temperature monitoring means each includes an isolation device and a cold junction compensator.
Claim 7
Dependent Claim
40 words
The medical probe device as set forth in claim 1, wherein the power supply means provides a pulsed electric current and the power supply means includes repetition rate adjustment means for varying the repetition rate of the pulsed electric current.
References Cited (Backward Citations)
US4998932A
Cited
US5135525A
Cited
US5029588A
Cited
US5007437A
Cited
US5084044A
Cited
US5010886A
Cited
US5002558A
Cited
US5057105A
Cited
US5007908A
Cited
US5109859A
Cited
US5035696A
Cited
US5170787A
Cited
US5122137A
Cited
US5080660A
Cited
US5071418A
Cited
US5190539A
Cited
US5083565A
Cited
US5100423A
Cited
US5059851A
Cited
US5120316A
Cited
AU1085892A
Cited
US5228441A
Cited
US5195965A
Cited
US5179962A
Cited
US5257451A
Cited
US5197963A
Cited
US5235964A
Cited
US5300099A
Cited
US5201732A
Cited
US5281218A
Cited
US5300069A
Cited
US1950788A
Cited
US1879249A
Cited
US1968997A
Cited
US2022065A
Cited
US2047535A
Cited
US2008526A
Cited
US2118631A
Cited
US2710000A
Cited
US3230957A
Cited
US3339542A
Cited
US3556079A
Cited
US3682162A
Cited
US3598108A
Cited
US3595239A
Cited
US3840016A
Cited
US3884237A
Cited
US3850175A
Cited
US3835842A
Cited
US3924628A
Cited
US3828780A
Cited
US3939840A
Cited
US3942530A
Cited
US3991770A
Cited
US4011872A
Cited
US3858577A
Cited
US3948270A
Cited
US4119102A
Cited
USRE32066E
Cited
US4137920A
Cited
US4312364A
Cited
US4136566A
Cited
US4154246A
Cited
US4228809A
Cited
US4204549A
Cited
US4311154A
Cited
US4402311A
Cited
US4295467A
Cited
US4448198A
Cited
US4267828A
Cited
US4311145A
Cited
US4307720A
Cited
US4375220A
Cited
US4411266A
Cited
US4565200A
Cited
US4805616A
Cited
US4562838A
Cited
US4452236A
Cited
US4397314A
Cited
US4568329A
Cited
US4470407A
Cited
US4494539A
Cited
US4405314A
Cited
US4676258A
Cited
US4774949A
Cited
US4672962A
Cited
US4601296A
Cited
US4798215A
Cited
US4612940A
Cited
US4682596A
Cited
US4552554A
Cited
US4697595A
Cited
US4706681A
Cited
US4800899A
Cited
US4580551A
Cited
US4817601A
Cited
US4594074A
Cited
US4669475A
Cited
US4681122A
Cited
US4785829A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-01-30 | 1998-08-01 | 1999-01-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-01-30 | 2002-08-01 | 2003-01-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-01-30 | 2006-08-01 | 2007-01-31 | $7700.00 | Window Closed / Lapsed |